Genmab appoints chief medical officer
On Monday, Genmab announces that the firm has appointed Tahamtan Ahmadi to the newly created position of chief medical officer
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
On Monday, biotech firm Genmab has appointed Tahamtan Ahmadi to be the firm's chief medical officer, from which position he will be responsible for the firm's experimental medicines, states the company in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Analyst emphasizes 2021 guidance in Genmab fiscal report
For subscribers
